DUCENTIS BIOTHERAPEUTICS
Ducentis is a pre-clinical stage company aiming to develop novel therapies for inflammation and autoimmune disease. Ducentis' target is the CD200/CD200R axis which imparts a deactivating signal to activated immune cells in both the innate and adaptive arms of the immune system. Potential therapeutic targets include transplant rejection and autoimmune and inflammatory diseases affecting the lungs, liver, kidney, eye, bone, and cartilage.
DUCENTIS BIOTHERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Medical Pharmaceutical
Founded:
2015-03-01
Address:
Witney, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.ducentisbio.com
Total Employee:
1+
Status:
Active
Contact:
+441993880504
Email Addresses:
[email protected]
Total Funding:
880 K GBP
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apache Microsoft Exchange Online Office 365 Mail
Similar Organizations
AimVion A/S
AimVion A/S is a privately held research and development company focused on peptide based drugs for inflammatory and autoimmune diseases.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Redoxis
Redoxis is a preclinical CRO with focus on inflammation and autoimmune conditions.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Synovo GmbH
Synovo GmbH is a drug discovery company with a primary focus on inflammation and innate immune processes
Current Employees Featured
Founder
Investors List
Capital Cell
Capital Cell investment in Angel Round - Ducentis BioTherapeutics
Oxford Technology Management
Oxford Technology Management investment in Angel Round - Ducentis BioTherapeutics
Oxford Technology Management
Oxford Technology Management investment in Seed Round - Ducentis BioTherapeutics
Official Site Inspections
http://www.ducentisbio.com
- Host name: a67c48129651a0940.awsglobalaccelerator.com
- IP address: 76.223.67.189
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
